A Study in Healthy Japanese Participants to Evaluate the Safety and Pharmacokinetics of Otilimab

Clinical trial NCT05304130 · WITHDRAWN

Trial details

NCT number: NCT05304130
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Arthritis, Rheumatoid

Start date: 2023-02-08
Primary completion: 2023-05-04
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.